Navigation Links
Sex and gender competency essential to medical care
Date:2/12/2013

The Food and Drug Administration recently announced a change to current dosages for sleeping medications in women to half the current prescribed level, and research suggests that flu dosages for women be reconsidered as well. Consideration of how women respond to medicine should be common practice, but we aren't there yet. To accelerate the integration of sex and gender influences into medical education and clinical training, the Sex and Gender Women's Health Collaborative (SGWHC) proudly announces the launch of the first and only digital resource dedicated solely to sex and gender evidence based care to promote health and improve disease outcomes. We invite you to visit us at: http://sgwhc.org.

"Both sex and gender have a major impact on health and wellbeing, and so should be considered in every aspect of medicine," says Kimberly Templeton, MD, Professor of orthopedic surgery at Kansas University Medical Center (Kansas City), and a board member of both the American Medical Women's Association and the American College of Women's Health Physicians, two founding partners of SGWHC.org.

"Mounting scientific evidence demonstrates unequivocally that women and men vary down to each cell. Sex differences in disease prevention and management should be recognized and applied to provide optimal health care for everyone," says Dr. Templeton.

"Historically, sex and gender focused health information has been fragmented and difficult to access, adversely impacting medical education and, ultimately, patient care. In response, SGWHC is advocating for universal inclusion of a culturally competent, sex- and gender-based approach to medical education and training," says, Janice Werbinski, MD, Medical Director of Borgess Women's Health in Kalamazoo, MI, and SGWHC executive director.

At SGWHC.org, medical students, nurse practitioners/nurses, and allied health faculty and providers have open access to the sing
'/>"/>

Contact: Jodi Godfrey
jgodfrey@sgwhc.org
973-809-5462
Sex and Gender Women's Health Collaborative
Source:Eurekalert

Page: 1 2

Related biology news :

1. APS issues new policy requiring identification of sex or gender in reporting scientific research
2. Researcher finds gender differences in seasonal auditory changes
3. Bacterial shock to recapture essential phosphate
4. Water, water everywhere - but is it essential to life?
5. New book on stereology by Mark West is essential reading for neurobiologists
6. Study details essential role of trust in agricultural biotech partnerships
7. Nature study reveals loss of essential blood cell gene leads to anemia
8. Scientists discover structure of protein essential for quality control, nerve function
9. Essential informatics methods and tools for analyzing the explosion of NGS data
10. Alnylam and UMass Medical School announce Tuschl I patent upheld in European opposition proceedings
11. Miniature pressure sensors for medical touch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
(Date:5/5/2015)... Conn. , May 5, 2015, NXT-ID, Inc. ... authentication company focused on the growing mobile commerce market, reminds ... Company,s Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS ... May 5-7, 2015. The three-day conference is ... David is speaking in is themed Global Fraud: Where ...
(Date:4/20/2015)... PASADENA, Calif. , April 20, 2015 ... San Gabriel Valley to implant a new miniaturized, wireless ... HF System is the first and only FDA-approved heart ... reduce hospital admissions when used by physicians to manage ... a sensor that is implanted in the pulmonary artery ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... for a "Fontaine de Jouvence" forever; a way to ... found, we are making,progress; in worms. Researchers found that ... of prolonging the life span of C.,Elegans: ,A class ... according to researchers at Washington University School of,Medicine in ...
... a,potential target for a drug seems very promising on ... case of telomerase inhibitors,to treat cancer; they are supposed ... cancer cells. Yet, something in the cell,seems to block ... to do then? Scrap the project? Look for something,else? ...
... to DNA and identifying the genes they regulate just ... by scientists at the U.S.,Department of Energy’s Brookhaven National ... the role these proteins,play in turning on and off ... they brain cells, liver, or blood ?as well as ...
Cached Biology News:Research on Worms Yields Clues on Aging 2Combination therapy boosts effectiveness of telomere-directed cancer cell death 2New Technique for Tracking Gene Regulators 2New Technique for Tracking Gene Regulators 3
(Date:5/21/2015)... St. Louis, MO (PRWEB) May 21, 2015 ... that assesses the safety and efficacy of pharmaceutical products ... Access Drive Maryland Heights, MO 63043, a 50,000 sq. ... their current location, to enable strategic growth. Facility renovations ... offices to the new space will occur in September. ...
(Date:5/21/2015)... 2015 uBiome, the leading startup ... with PicnicHealth, a healthcare company that collects and ... Inflammatory Bowel Disease (IBD) will receive a complementary ... research kit. Both companies were funded by Y ... For more information on this partnership and how ...
(Date:5/21/2015)... 21, 2015 Patent Offering, The patent’s ... diagnostic or therapeutic imaging within a body lumen (open ... endoscope having a low cost, single-use disposable illumination and ... was October 18, 2013 and the patent approval was ... the physician to customize the lighting and magnification of ...
(Date:5/21/2015)... - RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: ... on the development of autologous cell therapies, announced ... Society for Cellular Therapy (ISCT) on RepliCel,s autologous ... a Phase 1/2 clinical trial.  The presentation, taking ... PM to 7:00 PM local time, will review ...
Breaking Biology Technology:Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 3uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 3RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3
...  Intimate Bridge 2 Conception, Inc. (Ib2C™), a Pittsburgh-based direct-to-consumer ... announced today that it has closed on a $4.3 ... a private, Pennsylvania-based investment group and was joined by ... of this round for manufacturing and marketing to prepare ...
... coat of paint you put on the outside of your ... power the appliances and equipment on the inside. A ... made a major advance toward this vision by creating an ... "We want to do something transformative, to move beyond ...
... recently licensed from Yale University a new clinical diagnostic ... treating patients with melanoma to identify a subset of ... their lymph nodes, have a 40% risk of recurrence ... IHC testing method that enables measurement of protein biomarkers ...
Cached Biology Technology:Intimate Bridge 2 Conception, Inc. Receives $4.3M 2Intimate Bridge 2 Conception, Inc. Receives $4.3M 3Notre Dame researchers develop paint-on solar cells 2HistoRx Licenses Melanoma Assay from Yale University 2
Mycoplasma Removal Agent (MRA) has been developed for cell culture, to combat the widespread problems caused by contamination of cell cultures with mycoplasma....
albumin from bovine serum (BSA), 2,4-dinitrophenylated (DNP-BSA)...
Request Info...
albumin from bovine serum (BSA), Alexa Fluor® 647 conjugate...
Biology Products: